Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gao Guo

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
The Journal of Clinical Investigation|April 4, 2018
TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancerKe Gong, Gao Guo, David E Gerber, et al.
Nature Cell Biology|August 1, 2022
EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulationGao Guo, Ke Gong, Nicole Beckley, et al.
Science Translational Medicine|July 8, 2026
EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastomaArifa Nayab, Nouman Mughal, Meher Angez, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
The Journal of Clinical Investigation|April 4, 2018
TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancerKe Gong, Gao Guo, David E Gerber, et al.
Nature Cell Biology|August 1, 2022
EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulationGao Guo, Ke Gong, Nicole Beckley, et al.
Science Translational Medicine|July 8, 2026
EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastomaArifa Nayab, Nouman Mughal, Meher Angez, et al.
Pageof 6